141 related articles for article (PubMed ID: 28815210)
1. LpxK Is Essential for Growth of
Wei JR; Richie DL; Mostafavi M; Metzger LE; Rath CM; Sawyer WS; Takeoka KT; Dean CR
mSphere; 2017; 2(4):. PubMed ID: 28815210
[No Abstract] [Full Text] [Related]
2. Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.
Richie DL; Takeoka KT; Bojkovic J; Metzger LE; Rath CM; Sawyer WS; Wei JR; Dean CR
PLoS One; 2016; 11(8):e0160918. PubMed ID: 27526195
[TBL] [Abstract][Full Text] [Related]
3. A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii.
Richie DL; Wang L; Chan H; De Pascale G; Six DA; Wei JR; Dean CR
PLoS One; 2018; 13(3):e0193851. PubMed ID: 29505586
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.
Bojkovic J; Richie DL; Six DA; Rath CM; Sawyer WS; Hu Q; Dean CR
J Bacteriol; 2015 Dec; 198(4):731-41. PubMed ID: 26668262
[TBL] [Abstract][Full Text] [Related]
5. Interplay of Klebsiella pneumoniae
Mostafavi M; Wang L; Xie L; Takeoka KT; Richie DL; Casey F; Ruzin A; Sawyer WS; Rath CM; Wei JR; Dean CR
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381354
[TBL] [Abstract][Full Text] [Related]
6. Structure- and Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria.
Zhou P; Hong J
Acc Chem Res; 2021 Apr; 54(7):1623-1634. PubMed ID: 33720682
[TBL] [Abstract][Full Text] [Related]
7. A Complete Pathway Model for Lipid A Biosynthesis in Escherichia coli.
Emiola A; George J; Andrews SS
PLoS One; 2014; 10(4):e0121216. PubMed ID: 25919634
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of a lipid A precursor lacking the 4'-phosphate following inactivation of the Escherichia coli lpxK gene.
Garrett TA; Que NL; Raetz CR
J Biol Chem; 1998 May; 273(20):12457-65. PubMed ID: 9575203
[TBL] [Abstract][Full Text] [Related]
9. Genetic synergy between
Noel HR; Keerthi S; Ren X; Winkelman JD; Troutman JM; Palmer LD
mBio; 2024 Mar; 15(3):e0280423. PubMed ID: 38364179
[No Abstract] [Full Text] [Related]
10. Homeoviscous Adaptation of the Acinetobacter baumannii Outer Membrane: Alteration of Lipooligosaccharide Structure during Cold Stress.
Herrera CM; Voss BJ; Trent MS
mBio; 2021 Aug; 12(4):e0129521. PubMed ID: 34425709
[TBL] [Abstract][Full Text] [Related]
11. Genetic synergy in
Noel HR; Keerthi S; Ren X; Winkelman JD; Troutman JM; Palmer LD
bioRxiv; 2023 Sep; ():. PubMed ID: 37790371
[No Abstract] [Full Text] [Related]
12. Crystal structure of LpxK, the 4'-kinase of lipid A biosynthesis and atypical P-loop kinase functioning at the membrane interface.
Emptage RP; Daughtry KD; Pemble CW; Raetz CR
Proc Natl Acad Sci U S A; 2012 Aug; 109(32):12956-61. PubMed ID: 22826246
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic characterization of the tetraacyldisaccharide-1-phosphate 4'-kinase LpxK involved in lipid A biosynthesis.
Emptage RP; Pemble CW; York JD; Raetz CR; Zhou P
Biochemistry; 2013 Apr; 52(13):2280-90. PubMed ID: 23464738
[TBL] [Abstract][Full Text] [Related]
14. Characterization of
VanOtterloo LM; Macias LA; Powers MJ; Brodbelt JS; Trent MS
mBio; 2024 Mar; 15(3):e0301323. PubMed ID: 38349180
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli.
Barb AW; McClerren AL; Snehelatha K; Reynolds CM; Zhou P; Raetz CR
Biochemistry; 2007 Mar; 46(12):3793-802. PubMed ID: 17335290
[TBL] [Abstract][Full Text] [Related]
16. A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin.
McClerren AL; Endsley S; Bowman JL; Andersen NH; Guan Z; Rudolph J; Raetz CR
Biochemistry; 2005 Dec; 44(50):16574-83. PubMed ID: 16342948
[TBL] [Abstract][Full Text] [Related]
17. Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: Its effects on bacterial outer membrane permeability and efflux pumps.
Chusri S; Na-Phatthalung P; Siriyong T; Paosen S; Voravuthikunchai SP
Microbiol Res; 2014; 169(5-6):417-24. PubMed ID: 24103863
[TBL] [Abstract][Full Text] [Related]
18. A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466.
Cuny GD
Expert Opin Ther Pat; 2009 Jun; 19(6):893-9. PubMed ID: 19473108
[TBL] [Abstract][Full Text] [Related]
19. Mutants resistant to LpxC inhibitors by rebalancing cellular homeostasis.
Zeng D; Zhao J; Chung HS; Guan Z; Raetz CR; Zhou P
J Biol Chem; 2013 Feb; 288(8):5475-86. PubMed ID: 23316051
[TBL] [Abstract][Full Text] [Related]
20. Targeted lipopolysaccharide biosynthetic intermediate analysis with normal-phase liquid chromatography mass spectrometry.
Sawyer WS; Wang L; Uehara T; Tamrakar P; Prathapam R; Mostafavi M; Metzger LE; Feng B; Baxter Rath CM
PLoS One; 2019; 14(2):e0211803. PubMed ID: 30735516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
